Wells Fargo analyst Derek Archila upgraded Immunovant to Overweight from Equal Weight with a price target of $27, up from $10.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IMVT: